Salt Lake City, UT- June 6, 2016- Predictive Technology Group, Inc. (OTCPINK:PRED) announces the formation of a new wholly-owned subsidiary, Predictive Women’s Health.

Predictive Women’s Health is an entity that will concentrate on providing innovative treatments and solutions for women.

Management intends to focus its resources and technologies on improving patient outcomes for women.

For further information about PRED, contact Rich Kaiser, Investor Relations, YES INTERNATIONAL, 757-306-6090, and

About Predictive Technology Group, Inc.

Predictive Technology Group, Inc. (OTC PINK: PRED), through its wholly owned subsidiaries, revolutionizes the treatment of severe and debilitating diseases through the commercialization of novel therapeutics leveraged by proprietary gene-based companion diagnostics. The Company develops and/or acquires proprietary technologies that open windows into the origin of human disease and the role that genes and their related proteins play in diseases’ onsets and progressions. PRED’s subsidiaries use gene-based information as cornerstones in the development of new diagnostics that assess a person’s risk of illness and therapeutic products designed to prevent and treat diseases.

Forward-Looking Statements

To the extent any statements made in this release contain information that is not historical, these statements are essentially forward-looking and are subject to risks and uncertainties, including the difficulty of predicting FDA approvals, acceptance and demand for new vaccines and other pharmaceutical products, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, availability of raw materials, availability of additional intellectual property rights, availability of future financing sources, the regulatory environment and other risks the Company may identify from time to time in the future.